by Sasha Whitaker | Jul 14, 2023 | News, Press Releases
Published by BioBuzz.io – June 8, 2023 Contract research organizations (CROs) are an essential key to a thriving life sciences ecosystem. Maryland is home to multiple CROs that provide broad support to the development of therapeutics across a broad spectrum of...
by Sasha Whitaker | Apr 19, 2023 | Client Spotlights, FDA Announcements, FDA EUA News, News, Press Releases, Regulatory News
Biotoxtech, the No. 1 non-clinical CRO in Korea, and its affiliates (BTT Group) announce that they have signed a business agreement with CSSi LifeSciences, an American CRO, to strengthen new drug development support services. Based on both companies’ accumulated...
by Sasha Whitaker | Jun 2, 2022 | Regulatory Resources
Our faculty can provide a complimentary webinar on regulatory strategies for medical devices and therapeutics. Contact us here to request a...
by Sasha Whitaker | Jun 2, 2022 | Regulatory Resources
The US healthcare market is a complex, fragmented space. Our guide and checklist will facilitate a soft-landing to help grow you business the right way in the United States. Meeting the unmet need: The key to success in US market entry is picking the right commercial...
by Sasha Whitaker | Jun 2, 2022 | Regulatory Resources
FDA Encourages EUAs to Pursue Premarket Submissions - January 31st, 2023 The White House’s recent announcement that the Biden Administration plans to end the public health emergency on May 11th, 2023. In a statement released on January 31st, 2023, the FDA...
Recent Comments